Some people need longer-term treatment
Additionally, the Alzheimers Association released its first clinical practice guideline on the use of blood-based biomarkers in 2025, signaling that these tools are transitioning from research settings into real diagnostic pathways, grounding novel biomarkers into meaningful clinical action. Research into the treatment of Alzheimers disease continued to advance as well
Legere was recognized as a Rising Star from 2010 - 2012 and 2014 - 2015, and as a Super Lawyer in 2020 through 2025 Kelly C
The more intriguing possibility is that the drug does something beyond shrinking the patient
There was an increased number of thyroid cancers in the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) clinical trial evaluating liraglutide versus placebo, but the risk did not reach statistical significance (hazard ratio [HR] 1.66, 95% CI 0.406.95), as well as in a meta-analysis of 12 other clinical trials with liraglutide (odds ratio [OR] 1.54, 95% CI 0.406.02) (7,8)